Does Bromocriptine Increase Cancer Risk? the Concerns - Obstetrics and Gynecology

Share to:

Medications used to suppress lactation may be associated with an increased risk of cancer?


Doctor, I am currently taking a medication called "Bromocriptine 2.5mg" to suppress lactation, twice a day for a week.
Can this medication cause cancer? I am a bit worried after reading some articles online...

bubee, 20~29 year old female. Ask Date: 2017/05/05

Dr. Huang Jianzhong reply Obstetrics and Gynecology


Bromocriptine may cause drowsiness, dizziness, or light-headedness.
These effects may be exacerbated if taken with alcohol or certain medications.
Use bromocriptine with caution.
Do not drive or perform other potentially unsafe tasks until you know how it affects you.
Avoid alcohol while using bromocriptine.
Consult your doctor before using medications that may cause drowsiness (e.g., sleep aids, muscle relaxants) while on bromocriptine, as it may enhance their effects.
Ask your pharmacist if you have questions about which medications may cause drowsiness.
Bromocriptine may lead to dizziness, light-headedness, or fainting; alcohol, hot weather, exercise, and fever may intensify these effects.
To mitigate them, rise slowly from sitting or lying positions, especially in the morning.
Sit or lie down at the first sign of these effects.
Some individuals using bromocriptine may experience sudden severe drowsiness or may even fall asleep during routine daily activities (e.g., driving, eating, talking) without warning.
If this occurs, refrain from driving, operating machinery, or engaging in other potentially unsafe activities while using bromocriptine.
Inform your doctor immediately.
Do not abruptly discontinue bromocriptine, as some conditions may worsen upon sudden cessation.
Your doctor may need to gradually reduce your dose to avoid side effects (e.g., fever, muscle stiffness, confusion, abnormal thinking, rapid or irregular heartbeat, sweating).
If you are taking bromocriptine for a brain tumor, stopping it can lead to rapid tumor regrowth.
Do not stop taking bromocriptine without consulting your doctor.
Patients with Parkinson's disease may have an increased risk of developing a specific type of skin cancer (melanoma).
It is unclear whether bromocriptine also raises the risk of melanoma.
You may need to undergo skin examinations while using bromocriptine.
Notify your doctor if you observe any unusual skin growths or changes in the appearance of a mole.
Discuss any questions or concerns with your doctor.
Some individuals have reported new, unusual, or increased urges (e.g., gambling, sexual urges) while taking bromocriptine.
Inform your doctor immediately if you notice such effects.
Notify your doctor or dentist that you are taking bromocriptine before receiving any medical or dental care, emergency treatment, or surgery.
Bromocriptine may reduce the effectiveness of your birth control pill.
To prevent pregnancy, ensure you use an additional form of contraception (e.g., condoms) while taking bromocriptine.
Laboratory tests, including blood pressure, liver and kidney function, heart function, and blood cell counts, may be conducted to monitor your progress.
Be sure to attend all doctor and laboratory appointments.
Bromocriptine should be used with extreme caution in children younger than 11 years old; its safety and effectiveness in this age group have not been established.

Pregnancy and Breastfeeding: If you become pregnant, contact your doctor.
You will need to discuss the benefits and risks of using bromocriptine during pregnancy.
It is unknown if this medication is excreted in breast milk.
Do not breastfeed while taking bromocriptine.

Reply Date: 2017/05/05

More Info


Bromocriptine is a medication primarily used to treat conditions related to hyperprolactinemia, such as prolactin-secreting tumors (prolactinomas) and to suppress lactation. It works by mimicking the action of dopamine, a neurotransmitter that inhibits prolactin secretion from the pituitary gland. While your concerns about cancer risk are understandable, it is essential to clarify the relationship between Bromocriptine and cancer.

Current medical literature does not provide strong evidence that Bromocriptine directly increases the risk of cancer. However, there are some nuances to consider. For instance, patients with Parkinson's disease, who may be treated with dopamine agonists like Bromocriptine, have been observed to have a slightly higher risk of developing melanoma, a type of skin cancer. This association is not definitively linked to Bromocriptine itself but rather to the underlying condition and the medications used. Therefore, while there is a noted correlation, it does not imply causation.

Moreover, the potential side effects of Bromocriptine include dizziness, drowsiness, and gastrointestinal disturbances, but these are not indicative of an increased cancer risk. It is crucial to monitor for any unusual symptoms, particularly skin changes, and to maintain regular follow-ups with your healthcare provider. If you notice any new skin growths or changes in existing moles, it is advisable to consult your doctor promptly.

Regarding your specific situation of taking Bromocriptine for a week to suppress lactation, the short-term use of this medication is generally considered safe. Long-term use, particularly in the context of treating prolactinomas, is more complex and should be managed under the guidance of a healthcare professional. Regular monitoring through MRI scans may be necessary to assess the status of any tumors and to determine the effectiveness of the treatment.

If you are still concerned about the potential risks associated with Bromocriptine, it is essential to have an open discussion with your healthcare provider. They can provide personalized advice based on your medical history, current health status, and any family history of cancer. Additionally, they can discuss alternative treatment options if necessary.

In summary, while there are some associations between certain conditions and an increased risk of cancer, Bromocriptine itself is not widely recognized as a direct carcinogen. Your healthcare provider is the best resource for addressing your concerns and ensuring that you receive appropriate care tailored to your needs. Regular check-ups and open communication about your treatment plan can help alleviate your worries and ensure your health remains a priority.

Similar Q&A

Managing Prolactinoma: Long-Term Bromocriptine Use and Alternatives

Hello, doctor... I am a patient with a prolactinoma. I have been using Bromocriptine for a long time to suppress the progression of the condition, but I have been taking it for about three years, and my levels are still too high. May I ask: 1. Should I continue taking it? 2. Are ...


Dr. Ye Boshou reply Neurology
Currently, the medical treatment for prolactinomas involves the use of Bromocriptine, and it is recommended to monitor MRI for any enlargement. If there is an increase in size, surgical intervention may be considered.

[Read More] Managing Prolactinoma: Long-Term Bromocriptine Use and Alternatives


Concerns About Spironolactone Use and Breast Cancer Risk

Hello Dr. Chen, I have been experiencing acne for a long time. The medication prescribed to me has "diuretic" written on the bag, and I am wondering if it refers to Spironolactone. Recently, I read in a magazine that it should not be taken if there is a family history o...


Dr. Chen Yiying reply Dermatology
The diuretic you mentioned for treating acne is likely spironolactone. In fact, there is no evidence to support that the use of spironolactone increases the risk of breast cancer; however, it is suggested that patients with a family history of breast cancer should avoid its use. ...

[Read More] Concerns About Spironolactone Use and Breast Cancer Risk


Impact of SSRIs on Cancer Treatment: Insights and Concerns

Hello, Pharmacist Liu; I found a report indicating that SSRIs may interfere with cancer treatment here: www.libertytimes.com.tw/2002/new/mar/28/today-c10.htm Thank you.


Dr. Liu Huijun reply Pharmacology
Hello: The entire report does not indicate that antidepressants increase the risk of cancer. The study itself was limited to in vitro experiments in test tubes, and there have been no conclusions from human or even animal studies. Furthermore, this report is from 2002, and there ...

[Read More] Impact of SSRIs on Cancer Treatment: Insights and Concerns


Concerns About Milk Production After Taking Bromocriptine: What to Know

Hello, doctor. I had a miscarriage procedure in mid-April. After that, I noticed some hardening in my breasts, and the doctor prescribed me a lactation suppression medication (Bromocriptine). I took it for a week, and my breasts have softened. However, two weeks later, I still ha...


Dr. Huang Jianzhong reply Obstetrics and Gynecology
I had a miscarriage in mid-April. After that, I noticed some hardening in my breasts, and my doctor prescribed a lactation suppressant (Bromocriptine) for me. I took it for a week, and my breasts have softened. However, two weeks later, I still have a small amount of milk leaking...

[Read More] Concerns About Milk Production After Taking Bromocriptine: What to Know


Related FAQ

Prolactin

(Obstetrics and Gynecology)

Hyperprolactinemia

(Obstetrics and Gynecology)

Drug Side Effects

(Obstetrics and Gynecology)

Breast Cancer

(Obstetrics and Gynecology)

Hormonal Imbalance

(Obstetrics and Gynecology)

Abortion Pill

(Obstetrics and Gynecology)

Progesterone

(Obstetrics and Gynecology)

Human Papillomavirus

(Obstetrics and Gynecology)

Cancer Antigen 125

(Obstetrics and Gynecology)

Drug Interactions

(Obstetrics and Gynecology)